** Shares of Synlait Milk SML.NZ fall 3.3% to NZ$0.87, among biggest percentage loser in benchmark NZ50 .NZ50 index
** Macquarie says SML's strong first-half recovery of EBITDA was aided by advanced nutritional segment
** However, brokerage flags caution against repeat of first-half EBITDA in second half due to potential headwinds in ingredients business and others
** Bell Potter notes first-half adj. EBITDA exceeding forecast, with sales up 16% YOY, but warns about rival A2 Milk ATM.NZ possibly integrating their supply chain assets i.e. detrimental to SML's nutrition business
** Macquarie maintains 'underperform' rating but trims PT to NZ$0.47 from NZ$0.44
** Bell Potter maintains 'hold' but ups PT for ASX-listed shares SM1.AX to A$0.92 from A$0.90
** Stock has doubled in value YTD
(Reporting by Kumar Tanishk in Bengaluru)
((Tanishk.Kumar@thomsonreuters.com; X: @thatstanishk;))